| 0 (0%) | 11-30 07:30 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 11.47  |
1-year : | 13.39 |
| Resists | First : | 9.82 |
Second : | 11.47 |
| Pivot price | 4.56 |
|||
| Supports | First : | 5.77 |
Second : | 3.27 |
| MAs | MA(5) : | 5.97 |
MA(20) : | 4.3 |
| MA(100) : | 5.18 |
MA(250) : | 5.84  |
|
| MACD | MACD : | 0.6 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 92.1 |
D(3) : | 86.1 |
| RSI | RSI(14): 86.1 |
|||
| 52-week | High : | 13.19 | Low : | 0.66 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ VRCA ] has closed above the upper band by 28.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 212.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 6.79 - 6.81 | 6.81 - 6.84 |
| Low: | 5.44 - 5.47 | 5.47 - 5.49 |
| Close: | 6.66 - 6.7 | 6.7 - 6.74 |
Thu, 27 Nov 2025
Needham Maintains Verrica Pharmaceuticals(VRCA.US) With Hold Rating - 富途牛牛
Thu, 27 Nov 2025
Is VRCA stock ready for breakout - Dip Buying & Verified Short-Term Trading Plans - moha.gov.vn
Wed, 26 Nov 2025
$VRCA stock is up 20% today. Here's what we see in our data. - Quiver Quantitative
Tue, 25 Nov 2025
Biotech And Healthcare Names Lead After-Hours Gainers: ICU, CGTX, MESO, VRCA, AHCO - Nasdaq
Tue, 25 Nov 2025
Insider Purchase: CMO of $VRCA Buys 2,357 Shares - Quiver Quantitative
Mon, 24 Nov 2025
Verrica Pharmaceuticals (VRCA) Secures $50 Million Through PIPE Deal - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 9 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 43.4 (%) |
| Held by Institutions | 28.8 (%) |
| Shares Short | 420 (K) |
| Shares Short P.Month | 428 (K) |
| EPS | -7.74 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.89 |
| Profit Margin | 0 % |
| Operating Margin | 11.8 % |
| Return on Assets (ttm) | -52 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 145.3 % |
| Gross Profit (p.s.) | 0.53 |
| Sales Per Share | 1.55 |
| EBITDA (p.s.) | -3.94 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -47 (M) |
| Levered Free Cash Flow | -33 (M) |
| PE Ratio | -1.18 |
| PEG Ratio | 0 |
| Price to Book value | -4.82 |
| Price to Sales | 5.85 |
| Price to Cash Flow | -1.82 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|